IFNG and neoplasm: The ability of lenalidomide to induce the antitumor efficacy of the DC vaccine may be due to enhancing the proportion of IFN-γ-secreting lymphocytes and suppressing the proportions of Tregs and MDSCs in tumor-bearing mice [29].